VeriMomsalix alba/daphnoides/fragilis/purpurea bark extract est-il sûr pendant la grossesse ?
No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
Related ingredients
Frequently asked questions
- salix alba/daphnoides/fragilis/purpurea bark extract est-il sûr pendant la grossesse ?
- No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
- salix alba/daphnoides/fragilis/purpurea bark extract est-il sûr pendant l'allaitement ?
- No regulatory harmonised flag or authoritative safety assessment (SCCS/CIR) indicating reproductive or lactation hazards for Salix bark extracts. Theoretical transfer of small amounts of salicylates into circulation is possible from topical use, but expected to be low with typical cosmetic use; evidence for clinically relevant transfer into breast milk from cosmetic topical willow-bark is lacking.
- salix alba/daphnoides/fragilis/purpurea bark extract est-il sûr pour la peau de bébé ?
- No evidence that willow bark extract is a reproductive toxicant or teratogen in humans or animals in regulatory reviews. However, infants (0–3 yr) have higher dermal absorption per kg and a less mature barrier: if the extract contains measurable salicylates, exposure is plausibly higher (adult e=1 → infant e incremented to 2). There is limited/no infant-specific safety data for topical willow-bark-containing cosmetics.
- Comment VeriMom évalue-t-il salix alba/daphnoides/fragilis/purpurea bark extract ?
- VeriMom évalue salix alba/daphnoides/fragilis/purpurea bark extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à salix alba/daphnoides/fragilis/purpurea bark extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à salix alba/daphnoides/fragilis/purpurea bark extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.